Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.
Survival following allogeneic transplant in patients with myelofibrosis.
TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy.
Kelliher MA, Fitzgerald KA. TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy. Trends Immunol. 2023 03; 44(3):156-158.
View in:
PubMed
subject areas
Cell Death
Humans
Immunotherapy
Neoplasms
Receptor-Interacting Protein Serine-Threonine Kinases
authors with profiles
Michelle A Kelliher PhD
Katherine A Fitzgerald PhD